In today's rapidly changing healthcare landscape, staying informed on the latest health policy trends is crucial for effectively engaging with stakeholders and decision-makers.

Our on-demand webinar delves into 3 critical topics that are currently shaping the industry: the Inflation Reduction Act (IRA), health equity, and Pre-approval Information Exchange (PIE).

Discover how the IRA is set to impact drug pricing and spending, including the timeline for implementation and the potential effects on biopharma companies and learn about the strides being made to improve access to care for medically underserved patients through the implementation of health equity considerations.

Lastly, we'll explore how the PIE Act is transforming the way that biopharma companies and healthcare decision-makers exchange information, and the opportunities this presents in the digital era. Hear from AmerisourceBergen thought leaders, who will share their expert insights and help you stay ahead of the curve.

Key webinar learnings:

• The knowns and unknowns of the Inflation Reduction Act (IRA) and its potential impacts on the biopharma industry.
• Common challenges and gaps in health equity considerations and how stakeholders can overcome these barriers.
• The role of the Pre-approval Information Exchange (PIE) Act of 2022 on product commercialization planning and identify methods through which healthcare technology can be utilized.

Panelists:

Corey Ford, Vice President, Reimbursement & Policy InsightsAmerisourceBergen/Xcenda

Patricia Doykos, Executive Director, Health Equity, Corporate Affairs, Bristol-Myers Squibb

Nancy Young, Vice President, Commercialization Services, AmerisourceBergen

Moderator:

Tasmina Hydery, Associate Director, Digital Solutions, AmerisourceBergen/Xcenda